
News|Articles|April 1, 2002
Why physicians start or stop prescribing a drug: Literature review and formulary implications (PDF)
These authors report on their literature search of studies assessing the impact of factors influencing the diffusion of new drug therapies and physicians' adoption and eventual relinquishment of those therapies. They specifically explore how their finds can help better align physician prescribing with formulary objectives.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Cigna Announces ‘Rebate-Free’ Pharmacy Benefit Model Starting in 2027
2
PBM Reform Debate: Panelists Clash Over Spread Pricing and Rebates | AMCP Nexus 2025
3
Rebates Play a Major Role in Whether Health Plans Restrict Access to Specialty Drugs | AMCP Nexus 2025
4
Not Red. Not Blue. Healthcare Is a Populist Issue, Says Costa | AMCP Nexus 2025
5


















































